EHang Faces eVTOL Approval Delays, Breakeven Pushed to 2029-2030; UBS Cuts Price Target
Summary
EHang is facing significant delays in eVTOL approvals in Hefei and Guangzhou, pushing its breakeven timeline out to 2029-2030. This regulatory setback is a material blow to the company's commercialization efforts and future revenue projections, as reflected by UBS cutting its price target and trimming 2025 revenue estimates. The headline also mentions a $30 million share repurchase program, which was previously announced on June 8th. These delays add to recent concerns following financial restatements and identified material weaknesses in internal controls in May.
At the time of this announcement, EH was trading at $8.70 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $592.7M. The 52-week trading range was $7.72 to $20.45. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.